Imaging with Fluciclovine PET/CT May Improve Radiation Targeting in Recurrent Prostate Cancer

Imaging with Fluciclovine PET/CT May Improve Radiation Targeting in Recurrent Prostate Cancer
Patients receiving radiation therapy for recurrent prostate cancer after prostatectomy may have better outcomes if imaging with the positron emission tomography (PET) radiotracer fluciclovine is used to guide their treatment. Results from an ongoing study show that assessing tumors with fluciclovine PET/CT scans leads to significant differences in the areas to receive radiotherapy, compared to

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *